Psychologists in Claremont, CA Accepting Medicare
59 Psychologists found. Showing 41 - 59
 Dr. Ann Marie Morgan, PSY.D. Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 428 Harrison Ave, Suite 101a, Claremont, CA 91711 Phone: 909-399-3402 |
Traci Warner Lowenthal, TRACI LOWENTHAL Psychologist Medicare: Not Enrolled in Medicare Practice Location: 250 W 1st St Ste 340, Claremont, CA 91711 Phone: 909-240-7833 |
 Dr. Daniel Skenderian, PH.D. Psychologist - Clinical Medicare: Accepting Medicare Assignments Practice Location: 350 W 4th St, Claremont, CA 91711 Phone: 909-625-1123 Fax: 909-625-6023 |
Dr. Dale Wesley Beaman, PHD Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 250 W 1st St, Suite 242, Claremont, CA 91711 Phone: 909-621-9023 Fax: 909-482-2211 |
Dr. Karen M. Salter-moss, PH.D. Psychologist - Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 250 W 1st St, Suite 214, Claremont, CA 91711 Phone: 909-624-6005 Fax: 909-498-9443 |
Amber E Blews, PHD Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 405 N Indian Hill Blvd, Claremont, CA 91711 Phone: 323-345-1402 |
Dr. Janiel Henry, PSY.D. Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 114 N Indian Hill Blvd Ste B, Claremont, CA 91711 Phone: 909-603-9300 |
Dr. Olga Gabriela Castillo, PSY.D. Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 250 W 1st St Ste 312, Claremont, CA 91711 Phone: 562-904-3999 |
Dr. Kris A Reed, PHD LMFT Psychologist Medicare: Not Enrolled in Medicare Practice Location: 219 N Indian Hill Blvd, Suite 205, Claremont, CA 91711 Phone: 909-568-4790 |
Tamara L. Obregon Madera, PSY.D Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 219 N Indian Hill Blvd Ste 202a, Claremont, CA 91711 Phone: 626-386-3036 |
Dr. Michelle Heather Sokoloff, PSY.D Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 405 N Indian Hill Blvd, Claremont, CA 91711 Phone: 510-860-3106 |
Christine D. Scher, PH.D. Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 250 W 1st St Ste 352, Claremont, CA 91711 Phone: 909-267-8547 |
Dr. Gurucharan Singh Khalsa, PHD Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 428 Harrison Ave Ste 200, Claremont, CA 91711 Phone: 909-593-3798 Fax: 909-624-7002 |
Dr. Michael Riess Lewin, PH.D. Psychologist - Cognitive & Behavioral Medicare: Not Enrolled in Medicare Practice Location: 1601 Monte Vista Ave, Suite 270, Claremont, CA 91711 Phone: 909-537-7303 Fax: 909-537-7003 |
Dr. Charles Samuel Leeb, PH.D. Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 250 West First Street, Suite 246, Claremont, CA 91711 Phone: 909-238-8001 Fax: 909-399-9704 |
Dr. Erica Florence Rosenfeld, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 250 W 1st St, Suite 216, Claremont, CA 91711 Phone: 909-625-7730 Fax: 909-625-3352 |
Dr. Delores Eliza Mack, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 414 Yale Ave, Suite F, Claremont, CA 91711 Phone: 909-319-9956 Fax: 909-946-7133 |
Dr. Maurice Adam Levy, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 101 N Indian Hill Blvd Ste C1-200, Claremont, CA 91711 Phone: 866-200-9090 |
Dr. Jessica Borelli, PH.D. Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 647 N College Way, Claremont, CA 91711 Phone: 909-607-3757 |
News Archive
Targeted agent pacritinib significantly reduces burden of advanced myelofibrosis in patients
Use of the targeted agent pacritinib significantly reduced the symptoms and burden of advanced myelofibrosis in patients, says a Mayo Clinic researcher who co-led PERSIST-1, the worldwide phase III clinical trial that tested the therapy. Specifically, pacritinib substantially reduced severe enlargement of the spleen, a typical feature of advanced myelofibrosis, in more than 20 percent of patients and alleviated debilitating side effects in more than 46 percent.
Metabolic Solutions initiates MSDC-0602 Phase 2a trial in patients with type 2 diabetes
Metabolic Solutions Development Company, a drug discovery and development company exploiting novel molecular targets to treat metabolic diseases, announced today that it has launched a Phase 2a trial for MSDC-0602, the company's second drug candidate for the treatment of type 2 diabetes.
OSU researchers review studies on effectiveness of mindfulness-based programs for weight loss
If dieting is on your New Year agenda, it might pay to be mindful of a study suggesting there is little hard evidence that mindfulness leads to weight loss.
Researchers discover key details of how rheumatoid arthritis destroys bone
Researchers have discovered key details of how rheumatoid arthritis (RA) destroys bone, according to a study published in the Aug. 22 edition of the Journal of Biological Chemistry. The findings are already guiding attempts to design new drugs to reverse RA-related bone loss and may also address more common forms of osteoporosis with a few adjustments.
New research shows how brain function reflects the process of learning new words
Our vocabulary continues to grow and expand even in adulthood. Just ten years ago, the word 'blog' did not yet exist - and now we no longer remember when we heard this word for the first time or when we learned its meaning. At some stage new words become just as familiar to us as words we have learned earlier. One of the areas of interest in the Academy of Finland's Neuroscience Research Programme (NEURO) is how the process of learning new words is reflected in the function of the brain.
› Verified 3 days ago
Psychologists
Dentists
Counselors
Pharmacists
Clinical Social Workers
Occupational Therapists